sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > PDGFR
PDGFR
Cat.No. Product Name Information Area
T3476 JI-101 JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth fac... Cardiovascular
T6930 Pazopanib HCl (GW786034 HCl) Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEG... Others
T2288 Motesanib Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential... Cancer
T6711 Tyrphostin AG 1296 Tyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to E... Cancer
T6230 Imatinib (STI571) Imatinib is a tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BC... Cancer
T6124 Mubritinib (TAK 165)new Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM. Cancer
T6091 CP-673451 CP-673451 is a specific inhibitor of PDGFRα/β (IC50: 10/1 nM) with antiangiogenic and... Cancer
T3072 XL019 XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, 100 fold selectiv... Cancer
T2734 Sennoside B Sennoside B is an anthranoid. Anthranoid derivatives are used all over the world as a... Cancer
T2677 Crenolanib Crenolanib (CP-868596) is an effective and specific inhibitor of PDGFRα/β (Kd: 2.1/3.... Cancer
T2624 OSI-930 OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth fact... Cancer
T2609 Masitinib Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in... Cancer
T2516 Amuvatinib(MP470) Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineop... Cancer
T2514 Linifanib Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR ... Cancer
T2500 Cediranib Cediranib (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of... Cancer
T2479 Tyrphostin A9 Tyrphostin 9 is an Agricultural acaricide, now superseded. Tyrphostin 9 is firstly de... Cancer
T2446 KI8751 KI8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM. Cancer
T2415 PP121 PP-121 is a multi-targeted inhibitor of PDGFR (IC50: 2 nM), Hck (IC50: 8 nM), mTOR (I... Cancer
T2372 Ponatinib Ponatinib is a tyrosine kinase receptor inhibitor that is used in the therapy of refr... Cardiovascular System
T2288L Motesanib Diphosphate (AMG-706) Motesanib Diphosphate is the orally bioavailable diphosphate salt of a multiple-recep... Cancer
T2070 CEP-32496 CEP-32496 is a highly potent inhibitor of BRAF. Other
T2047 AG-1478 AG-1478 (Tyrphostin AG-1478) is a selective EGFR inhibitor. Cancer
T1895 SKLB610 SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kin... Cancer
T1836 AZD2932 AZD2932 is a potent and multi-targeted kinase inhibitor VEGFR2, PDGFβ, Flt-3, and c-K... Other
T1792 Regorafenib Regorafenib is a Kinase Inhibitor. The mechanism of action of regorafenib is as a Pro... Cancer
T1785 Palbociclib Palbociclib is an orally available cyclin-dependent kinase (CDK) inhibitor with poten... Cancer
T1777 BIBF 1120 Nintedanib is an orally bioavailable, indolinone-derived, receptor tyrosine kinase (R... Other
T1667 Tandutinib Tandutinib (MLN518, CT53518), an effective FLT3 antagonist (IC50: 0.22 μM), can also ... Cancer
T1621 Imatinib Mesylate Imatinib mesylate is a specific tyrosine kinase receptor inhibitor with antineoplasti... Cancer
T1452 Axitinib Axitinib is an orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the p...
1